Safety, Tolerability, and Pharmacokinetics of Oral NX-13 in Active Ulcerative Colitis
Public ClinicalTrials.gov record NCT04862741. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral NX-13 in Active Ulcerative Colitis
Study identification
- NCT ID
- NCT04862741
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Landos Biopharma Inc.
- Industry
- Enrollment
- 39 participants
Conditions and interventions
Conditions
Interventions
- NX-13 250mg IR Drug
- NX-13 500mg IR Drug
- NX-13 500mg MR Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 4, 2021
- Primary completion
- Jun 16, 2022
- Completion
- Oct 4, 2022
- Last update posted
- Feb 14, 2023
2021 – 2022
United States locations
- U.S. sites
- 22
- U.S. states
- 11
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Avant Research Associates LLC | Huntsville | Alabama | 35802 | — |
| Om Research LLC | Lancaster | California | 93534 | — |
| Allameh Medical Corporation | Mission Viejo | California | 92691 | — |
| California Medical Research Associates, Inc. | Northridge | California | 91324 | — |
| Clinical Research of California | Walnut Creek | California | 94598 | — |
| I.H.S Health LLC | Kissimmee | Florida | 34741 | — |
| University of Miami Crohn's and Colitis Center | Miami | Florida | 33136 | — |
| Valencia Medical and Research Center | Miami | Florida | 33165 | — |
| Care Access | Orlando | Florida | 32825 | — |
| Gastroenterology Associates of Pensacola, P.A. | Pensacola | Florida | 32503 | — |
| Atlanta Center for Gastroenterology, P.C. | Decatur | Georgia | 30033 | — |
| Care Access | New York | New York | 10065 | — |
| Care Access | Lumberton | North Carolina | 28538 | — |
| Optimed Research, LTD | Columbus | Ohio | 43235 | — |
| Care Access | Pottsville | Pennsylvania | 17901 | — |
| Galen Medical Group | Chattanooga | Tennessee | 37404 | — |
| Avant Research Associates, LLC | Austin | Texas | 78742 | — |
| Biopharma Informatics, LLC | Houston | Texas | 77084 | — |
| LinQ Research, LLC | Pearland | Texas | 77584 | — |
| Southern Star Research Institute, LLC | San Antonio | Texas | 78229 | — |
| Victoria Gastroenterology | Victoria | Texas | 77904 | — |
| Care Access Research, Salt Lake City | Salt Lake City | Utah | 84124 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04862741, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 14, 2023 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04862741 live on ClinicalTrials.gov.